The estimated Net Worth of Patrick Miles is at least $1.02 Miliarda dollars as of 25 September 2023. Mr. Miles owns over 179,375 units of Alphatec Inc stock worth over $29,717,411 and over the last 20 years he sold ATEC stock worth over $986,056,303. In addition, he makes $7,960,100 as Chairman of the Board, President a Chief Executive Officer at Alphatec Inc.
Patrick has made over 98 trades of the Alphatec Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he sold 179,375 units of ATEC stock worth $2,270,888 on 25 September 2023.
The largest trade he's ever made was exercising 317,461 units of Alphatec Inc stock on 17 May 2018 worth over $1,730,162. On average, Patrick trades about 24,436 units every 47 days since 2004. As of 25 September 2023 he still owns at least 5,452,736 units of Alphatec Inc stock.
You can see the complete history of Mr. Miles stock trades at the bottom of the page.
Patrick S. Miles serves as Chairman of the Board, President, Chief Executive Officer of the Company. He served as the Executive Chairman from October 2017 to March 2018. Mr. Miles has over 20 years of experience in the orthopedic industry and most recently served, from September 2016 to September 2017, as the Vice Chairman of NuVasive, Inc. where he was responsible for enhancing that company’s strategic plans for the future of spine surgery and supporting technology development. Mr. Miles also served as a member of NuVasive, Inc.’s Board of Directors from August 2015 until his resignation in September 2017. From February 2015 to August 2016, Mr. Miles served as NuVasive Inc.’s President and Chief Operating Officer. He previously served as NuVasive Inc.’s President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, Senior Vice President of Marketing from December 2004 to January 2007, and as its Vice President, Marketing from January 2001 to December 2004. Prior to those positions, he served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, and held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.
As the Chairman of the Board, President a Chief Executive Officer of Alphatec Inc, the total compensation of Patrick Miles at Alphatec Inc is $7,960,100. There are no executives at Alphatec Inc getting paid more.
Patrick Miles is 54, he's been the Chairman of the Board, President a Chief Executive Officer of Alphatec Inc since 2018. There are 9 older and 17 younger executives at Alphatec Inc. The oldest executive at Alphatec Holdings Inc is Ward Woods, 77, who is the Independent Director.
Patrick's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.
Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster a Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
Alphatec Inc executives and other stock owners filed with the SEC include: